U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Jun 26 18:21:20 UTC 2021
Edited
by admin
on Sat Jun 26 18:21:20 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin MOUSE CHIMERIC
Sequence Type COMPLETE
Record UNII
PQX0D8J21J
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
CETUXIMAB
EMA EPAR   HSDB   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
C-225
Code English
ERBITUX
Brand Name English
IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER
Common Name English
IMC-C225
Code English
C225
Code English
CETUXIMAB [INN]
Common Name English
IMC-225
Code English
CETUXIMAB (GENETICAL RECOMBINATION) [JAN]
Common Name English
CETUXIMAB [WHO-DD]
Common Name English
FV REGIONS OF MURINE ANTI-EGFR ANTIBODY WITH HUMAN IGG1 HEAVY AND KAPPA LIGHT CHAIN CONSTANT REGIONS, MW 152000
Common Name English
CETUXIMAB (GENETICAL RECOMBINATION)
JAN  
Common Name English
CETUXIMAB [PURPLE BOOK, CDER]
Common Name English
IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER
Common Name English
CETUXIMAB [MI]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER
Common Name English
MOAB C225
Code English
CETUXIMAB [MART.]
Common Name English
CETUXIMAB [USAN]
Common Name English
EXTRACELLULAR DOMAIN HUMAN EGFR BINDING RECOMBINANT, HUMAN/MOUSE CHIMERIC MONOCLONAL ANTIBODY
Common Name English
CETUXIMAB [HSDB]
Common Name English
CETUXIMAB [VANDF]
Common Name English
CETUXIMAB [EMA EPAR]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 237907
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
NDF-RT N0000020010
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
WHO-ATC L01XC06
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
WHO-VATC QL01XC06
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
LIVERTOX 181
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
NDF-RT N0000175664
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
NDF-RT N0000020010
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
NCI_THESAURUS C133878
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
NCI_THESAURUS C1742
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
EMA ASSESSMENT REPORTS ERBITUX (AUTHORIZED: COLORECTAL NEOPLASMS, HEAD AND NECK NEOPLASMS)
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
NCI_THESAURUS C129822
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
FDA ORPHAN DRUG 132700
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
Code System Code Type Description
MESH
C411189
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
EVMPD
SUB01178MIG
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
INN
7906
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
FDA UNII
PQX0D8J21J
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
RXCUI
318341
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY RxNorm
EVMPD
SUB127096
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
WIKIPEDIA
CETUXIMAB
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
DRUG BANK
DB00002
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
NCI_THESAURUS
C1723
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
EPA CompTox
205923-56-4
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
IUPHAR
6882
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
HSDB
7454
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
DRUG CENTRAL
4954
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
MERCK INDEX
M3296
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY Merck Index
ChEMBL
CHEMBL1201577
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
CAS
205923-56-4
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
LACTMED
Cetuximab
Created by admin on Sat Jun 26 18:21:21 UTC 2021 , Edited by admin on Sat Jun 26 18:21:21 UTC 2021
PRIMARY
From To
1_22 1_95
1_146 1_202
1_222 3_214
1_228 2_228
1_231 2_231
1_263 1_323
1_369 1_427
2_22 2_95
2_146 2_202
2_222 4_214
2_263 2_323
2_369 2_427
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_88
N 1_299
N 2_88
N 2_299
Related Record Type Details
SUB_CONCEPT->SUBSTANCE
TARGET -> INHIBITOR
TARGET -> AGONIST
BIOSIMILAR -> PARENT
SUB_CONCEPT->SUBSTANCE
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL